Phathom Pharmaceuticals Inc

PHAT NASDAQ Healthcare & Biotech United States US71722W1071
9.18 $
2.68 %

Phathom Pharmaceuticals specializes in the development and commercialization of drugs for the treatment of gastrointestinal diseases.